Literature DB >> 12870126

Differences in participation of innate and adaptive immunity to respiratory syncytial virus in adults and neonates.

Subramaniam Krishnan1, Mary Craven, Robert C Welliver, Nafees Ahmad, Marilyn Halonen.   

Abstract

Innate and adaptive immune responses to respiratory syncytial virus (RSV) in neonates were assessed by cord blood mononuclear cell (MC) cytokine expression and proliferation and these responses were compared with those from adult peripheral blood MCs. In adult cells, inactivated and live virus invoked cytokines reflecting both innate and adaptive immunity (interleukin [IL]-6, interferon [IFN]-gamma, IL-2, tumor necrosis factor [TNF]-alpha, and IL-10). Low levels of IL-4 were detected, although only with inactivated virus. In contrast, in neonatal cells, inactivated virus invoked large levels of the innate immune cytokines IL-6, TNF-alpha, and IL-10 and reduced levels of IFN-gamma and IL-12 but no adaptive cytokines. Live virus induced fewer innate (IL-6, IL-10, and IFN-gamma) and no adaptive immune cytokines. RSV-induced proliferation was absent in neonatal MCs, although positive in adult MCs. Thus, exposure to RSV does not appear to occur before birth, and adaptive immune insufficiency or greater innate responses may account for early life RSV-induced illnesses.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12870126     DOI: 10.1086/376530

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  17 in total

1.  Transforming growth factor beta is a major regulator of human neonatal immune responses following respiratory syncytial virus infection.

Authors:  Natalie J Thornburg; Bryan Shepherd; James E Crowe
Journal:  J Virol       Date:  2010-10-06       Impact factor: 5.103

Review 2.  Neonatal innate immunity to infectious agents.

Authors:  László Maródi
Journal:  Infect Immun       Date:  2006-04       Impact factor: 3.441

Review 3.  Viral and host factors in human respiratory syncytial virus pathogenesis.

Authors:  Peter L Collins; Barney S Graham
Journal:  J Virol       Date:  2007-10-10       Impact factor: 5.103

4.  Differential expression of ovine innate immune genes by preterm and neonatal lung epithelia infected with respiratory syncytial virus.

Authors:  Kenji Kawashima; David K Meyerholz; Jack M Gallup; Branka Grubor; Tatjana Lazic; Howard D Lehmkuhl; Mark R Ackermann
Journal:  Viral Immunol       Date:  2006       Impact factor: 2.257

5.  The middle ear immune defense changes with age.

Authors:  Michelle Christine Nielsen; Morten Friis; Tomas Martin-Bertelsen; Ole Winther; Lennart Friis-Hansen; Per Cayé-Thomasen
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-01-07       Impact factor: 2.503

6.  Murine hepatitis virus strain 1 produces a clinically relevant model of severe acute respiratory syndrome in A/J mice.

Authors:  Nadine De Albuquerque; Ehtesham Baig; Xuezhong Ma; Jianhua Zhang; William He; Andrea Rowe; Marlena Habal; Mingfeng Liu; Itay Shalev; Gregory P Downey; Reginald Gorczynski; Jagdish Butany; Julian Leibowitz; Susan R Weiss; Ian D McGilvray; M James Phillips; Eleanor N Fish; Gary A Levy
Journal:  J Virol       Date:  2006-11       Impact factor: 5.103

7.  Differential expression of cytokine transcripts in neonatal and adult ovine alveolar macrophages in response to respiratory syncytial virus or toll-like receptor ligation.

Authors:  Sasha J Fach; Alicia Olivier; Jack M Gallup; Theresa E Waters; Mark R Ackermann; Howard D Lehmkuhl; Randy E Sacco
Journal:  Vet Immunol Immunopathol       Date:  2010-02-13       Impact factor: 2.046

Review 8.  The immune response to respiratory syncytial virus infection: friend or foe?

Authors:  Robert C Welliver
Journal:  Clin Rev Allergy Immunol       Date:  2008-04       Impact factor: 8.667

Review 9.  Lamb model of respiratory syncytial virus-associated lung disease: insights to pathogenesis and novel treatments.

Authors:  Mark R Ackermann
Journal:  ILAR J       Date:  2014

10.  Primary human mDC1, mDC2, and pDC dendritic cells are differentially infected and activated by respiratory syncytial virus.

Authors:  Teresa R Johnson; Christina N Johnson; Kizzmekia S Corbett; Gretchen C Edwards; Barney S Graham
Journal:  PLoS One       Date:  2011-01-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.